---

---

therapeutics   entities : Akebia therapeutics, inc.   

save search

---

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-02 (Crawled : 20:00) - prnewswire.com
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| -7.59% | O: 0.63% H: 0.0% C: -6.29%
nasdaq grants therapeutics

---

Vafseo® approved by the U.S. FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients
Published: 2024-03-28 (Crawled : 07:00) - prnewswire.com
TVTX | $6.32 -0.78% -0.79% 1.2M |

Health Technology

| -16.95% | O: 0.91% H: 3.1% C: -0.39%
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| -34.82% | O: 10.27% H: 0.4% C: -25.91%
vafseo fda disease kidney anemia approved treatment

---

Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
Published: 2024-03-28 (Crawled : 01:00) - prnewswire.com
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| -34.82% | O: 10.27% H: 0.4% C: -25.91%
vafseo fda disease kidney anemia approval treatment dialysis

---

Akebia Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-11 (Crawled : 21:00) - prnewswire.com
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| 1.39% | O: 0.69% H: 0.0% C: -2.07%
report year therapeutics financial results

---

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-01 (Crawled : 21:00) - prnewswire.com
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| Email alert Add to watchlist
nasdaq grants therapeutics

---

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-02-02 (Crawled : 21:00) - prnewswire.com
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| Email alert Add to watchlist
nasdaq grants therapeutics

---

TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer
Published: 2024-01-29 (Crawled : 12:00) - globenewswire.com
ZVRA | $4.79 -0.21% -0.21% 240K |

n/a

| -19.67% | O: 0.42% H: 3.33% C: 2.83%
TCRX | $7.66 -1.16% -1.17% 120K |

Professional, Scientific, and T...

| 54.38% | O: -1.2% H: 7.46% C: 5.65%
SNY | $46.22 0.63% 0.63% 1.7M |

Health Technology

| -8.41% | O: 0.12% H: 0.0% C: 0.0%
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| -9.88% | O: 0.62% H: 11.66% C: 9.82%
therapeutics financial

---

Akebia Therapeutics Announces Appointment of Nicholas Grund as Chief Commercial Officer
Published: 2024-01-09 (Crawled : 14:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M |

Health Technology

| -10.87% | O: 0.74% H: 0.0% C: 0.0%
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| -7.01% | O: 1.27% H: 0.0% C: -1.89%
commercial therapeutics

---

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-01-02 (Crawled : 22:00) - prnewswire.com
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| 14.96% | O: 1.57% H: 6.98% C: 6.2%
nasdaq grants therapeutics

---

Akebia Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2023-12-20 (Crawled : 14:00) - biospace.com/
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| 22.69% | O: 0.84% H: 2.5% C: 0.0%
conference therapeutics

---

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-12-01 (Crawled : 21:00) - prnewswire.com
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| Email alert Add to watchlist
nasdaq grants therapeutics

---

Akebia Therapeutics to Present at Piper Sandler Healthcare Conference
Published: 2023-11-20 (Crawled : 13:00) - prnewswire.com
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| 46.0% | O: 0.0% H: 6.0% C: 2.0%
conference therapeutics

---

Akebia Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Published: 2023-11-08 (Crawled : 12:30) - prnewswire.com
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| 33.94% | O: -5.5% H: 3.88% C: -6.8%
business therapeutics financial results

---

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-11-01 (Crawled : 20:00) - prnewswire.com
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| 65.53% | O: 0.91% H: 5.62% C: -0.73%
nasdaq grants therapeutics

---

Akebia Therapeutics to Report Third Quarter 2023 Financial Results and Discuss Recent Business Highlights
Published: 2023-10-31 (Crawled : 20:00) - biospace.com/
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| 72.62% | O: 1.5% H: 4.82% C: 2.5%
report business therapeutics financial results

---

Akebia Receives FDA Acceptance of Resubmission to NDA of Vadadustat for the Treatment of Anemia due to Chronic Kidney Disease
Published: 2023-10-25 (Crawled : 13:00) - biospace.com/
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| 70.36% | O: -0.82% H: 3.51% C: -5.88%
fda disease kidney resubmission anemia treatment

---

Akebia Therapeutics Announces Five Poster Presentations at ASN Kidney Week 2023
Published: 2023-10-18 (Crawled : 13:30) - biospace.com/
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| 60.92% | O: -0.08% H: 3.56% C: -4.39%
kidney week therapeutics

---

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-10-03 (Crawled : 20:00) - prnewswire.com
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| 39.05% | O: 0.95% H: 8.49% C: 4.72%
nasdaq grants therapeutics

---

Akebia Announces Approval of Vafseo® (vadadustat) in Australia and Provides Commercial Update
Published: 2023-09-26 (Crawled : 17:00) - biospace.com/
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| 29.2% | O: 0.88% H: 9.65% C: 2.63%
vafseo australia approval update commercial

---

Akebia Therapeutics to Present at H.C. Wainwright Global Investment Conference - September 6, 2023
Published: 2023-09-06 (Crawled : 14:30) - biospace.com/
AKBA | $1.4 -4.11% -4.29% 3.8M |

Health Technology

| 19.67% | O: 1.64% H: 6.45% C: 0.81%
conference global therapeutics

---

Gainers vs Losers

49%

51%

Top 10 Gainers

KAVL | $6.275 135.02% 57.45% 44M |

Wholesale Trade

PXMD | $0.7375 79.09% 44.16% 4.5M |

Health Technology

DYNT | $0.371 -5.12% 43.09% 3.3M |

Health Technology

LGVN P 3 d | $2.94 73.96% 42.52% 57M |

HUBC | $1.94 49.23% 32.99% 73M |

n/a

SPCB | $0.4044 46.52% 31.75% 130M |

Electronic Technology

ONVO | $1.34 32.66% 24.62% 54M |

Health Technology

OMQS | $0.6869 32.1% 24.3% 3.6M |

Professional, Scientific, and T...

SNPO | $10.555 29.67% 22.88% 4M |

AMBI | $3.72 -26.77% 21.77% 9.8K |

n/a

---

Your saved searches

---